Incidence and Treatment of Leiomyosarcoma in Young Girls
Leiomyosarcoma is extremely rare in young girls, with an incidence of less than 2 per 1,000 per year, and treatment should focus on wide surgical excision with negative margins as the primary intervention. 1
Epidemiology and Incidence
Leiomyosarcoma (LMS) is exceedingly uncommon in the pediatric population:
- Soft tissue sarcomas as a group have an overall incidence of 4-5/100,000/year in Europe 1
- Leiomyosarcoma specifically has an incidence of less than 1/100,000/year 1
- In children, leiomyosarcoma represents an even smaller fraction of these already rare tumors
- Most leiomyosarcomas occur in adults, particularly in perimenopausal and postmenopausal women 2
- When occurring in children, there is no significant gender predilection (11 girls and 9 boys in one series) 3
Clinical Presentation in Young Girls
When leiomyosarcoma does occur in young girls, it typically presents as:
- Small, localized tumors in soft tissues 3
- Most commonly affecting:
- Trunk (30%)
- Head and neck (25%)
- Lower limbs (25%)
- Upper limbs (20%) 3
- Median age of 12 years (range 4-15 years) in pediatric cases 3
- Median tumor size of 2.5 cm (range 0.5-13 cm) 3
- Rare cases of primary gastric leiomyosarcoma have been reported in adolescents 4
Pathological Features
Pediatric leiomyosarcomas have distinct pathological characteristics:
- Majority (85%) are low-grade tumors 3
- Show typical features of smooth muscle differentiation with fascicles of eosinophilic spindle cells with cigar-shaped nuclei 3
- Immunohistochemically positive for:
- Alpha-smooth muscle actin (89%)
- HHF-35 (87%)
- Desmin (61%) 3
- Histologic criteria for malignancy include increased mitoses, cellular pleomorphism, and thrombotic degeneration 1, 2
Treatment Approach
The treatment of leiomyosarcoma in young girls should follow these principles:
Surgical Management:
Adjuvant Therapy:
Prognosis and Follow-up
Pediatric leiomyosarcoma has a distinct prognostic profile:
- Generally more favorable than adult leiomyosarcoma 3
- Relatively indolent behavior in most pediatric cases 3
- 5-year overall survival rate of approximately 79% 6
- 10-year survival rate decreases to approximately 49% 6
- Late recurrences can occur, even beyond 10 years 6
- Important prognostic factors include:
- Tumor grade (high-grade tumors have worse prognosis)
- Surgical margins (complete vs. incomplete resection)
- Tumor size 6
Special Considerations
- Multidisciplinary approach involving pediatric oncologists, surgeons, radiation oncologists, and pathologists is essential 1
- Treatment should be carried out in reference centers for sarcomas with expertise in pediatric oncology 1
- Long-term follow-up is critical due to the risk of late recurrences 6
- Differential diagnosis includes infantile myofibromatosis, leiomyoma, monophasic synovial sarcoma, and spindle cell rhabdomyosarcoma 3
Genetic Considerations
In rare cases, leiomyosarcoma may be associated with genetic syndromes:
- Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome due to FH gene mutations 1
- Annual skin examinations are recommended for children with FH mutations to assess for cutaneous leiomyomas and changes suggestive of leiomyosarcoma 1
While leiomyosarcoma is extremely rare in young girls, awareness of its clinical presentation, appropriate diagnostic workup, and treatment principles is essential for optimal outcomes in these challenging cases.